Philippe Camparo

Summary

Country: France

Publications

  1. ncbi [A problematic lymph node]
    Yankhoba Diop
    Service d Anatomie et Cytologie Pathologiques, Hopital d Instruction des armees BEGIN, 69 avenue de Paris, 94160 Saint Mande
    Ann Pathol 26:469-71. 2006
  2. ncbi Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma
    Eva Comperat
    Pathologic Anatomy Service and Urology Service, hôpital La Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, Parie, Frances
    Anal Quant Cytol Histol 32:39-44. 2010
  3. doi Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature
    Philippe Camparo
    HIA Val de Grace, Van Andel Research Institute, Paris, France
    Am J Surg Pathol 32:656-70. 2008
  4. ncbi [Molecular aspects of prostate cancer: recent data from the literature]
    Philippe Camparo
    Laboratoire d anatomie et cytologie pathologiques, Hôpital d Instruction des Armées Val de Grâce, 74 boulevard de Port Royal, 75005 Paris
    Bull Cancer 94:F77-88. 2007
  5. doi [Histological features and principles of treating testicle tumors in the elderly subject]
    P Camparo
    Service d Anatomie et Cytologie Pathologiques, Hopital Foch, 40, rue Worth, 92150 Suresnes, France
    Prog Urol 19:S142-6. 2009
  6. ncbi Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer
    Michael Peyromaure
    Department of Urology, Cichin Hospital, Paris, France
    Oncol Rep 18:145-9. 2007
  7. ncbi The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy
    Kaili Mao
    Department of Urology, Cochin Hospital, Paris, France
    Can J Urol 15:4257-62. 2008
  8. ncbi Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
    Sylvia Scarpini
    Academic Pathology Department, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Urol Oncol 30:182-7. 2012
  9. doi Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage
    Justine Varinot
    Department of Pathology, Pitie Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France
    Virchows Arch 455:449-53. 2009
  10. doi Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy
    Eva Comperat
    ER2, University PMC Paris VI, CeRePP, Paris, France
    Prostate 70:1622-7. 2010

Collaborators

Detail Information

Publications26

  1. ncbi [A problematic lymph node]
    Yankhoba Diop
    Service d Anatomie et Cytologie Pathologiques, Hopital d Instruction des armees BEGIN, 69 avenue de Paris, 94160 Saint Mande
    Ann Pathol 26:469-71. 2006
  2. ncbi Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma
    Eva Comperat
    Pathologic Anatomy Service and Urology Service, hôpital La Pitié Salpêtrière, AP HP, Universite Pierre et Marie Curie, Parie, Frances
    Anal Quant Cytol Histol 32:39-44. 2010
    ..To explore Foxp3, a member of the forkhead box family of transcription factors, which is a major gene for regulatory T (Treg) cell development of CD4+CD25+ or CD8+CD25+ phenotype...
  3. doi Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature
    Philippe Camparo
    HIA Val de Grace, Van Andel Research Institute, Paris, France
    Am J Surg Pathol 32:656-70. 2008
    ..Our results suggest that these differentially expressed genes may serve as novel diagnostic or prognostic markers...
  4. ncbi [Molecular aspects of prostate cancer: recent data from the literature]
    Philippe Camparo
    Laboratoire d anatomie et cytologie pathologiques, Hôpital d Instruction des Armées Val de Grâce, 74 boulevard de Port Royal, 75005 Paris
    Bull Cancer 94:F77-88. 2007
    ..Nevertheless, the possibility of decrypting these anomalies for use in therapeutic applications is encouraging...
  5. doi [Histological features and principles of treating testicle tumors in the elderly subject]
    P Camparo
    Service d Anatomie et Cytologie Pathologiques, Hopital Foch, 40, rue Worth, 92150 Suresnes, France
    Prog Urol 19:S142-6. 2009
    ..This particular histological profile must be in mind when considering the appropriate therapeutic approach of testis tumors in elderly. This work is based on data collected between 1990 to 2005 by the french pathologists of the GELU...
  6. ncbi Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer
    Michael Peyromaure
    Department of Urology, Cichin Hospital, Paris, France
    Oncol Rep 18:145-9. 2007
    ..01). Our results suggest that the expression of VEGF may have a prognostic impact in clinically-localized PCa...
  7. ncbi The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy
    Kaili Mao
    Department of Urology, Cochin Hospital, Paris, France
    Can J Urol 15:4257-62. 2008
    ..To study the prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor VEGFR-1 in localized prostate cancer...
  8. ncbi Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
    Sylvia Scarpini
    Academic Pathology Department, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Urol Oncol 30:182-7. 2012
    ..To investigate whether overexpression of p53, MIB-1, and Aurora-A on protein level played a role in the relapse of urothelial carcinomas of the upper urinary tract (UC-UUT)...
  9. doi Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage
    Justine Varinot
    Department of Pathology, Pitie Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France
    Virchows Arch 455:449-53. 2009
    ..Data are similar to those published in the recent literature, where whole mount sections were used. This protocol also permits better detection of concomitant prostate carcinomas...
  10. doi Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy
    Eva Comperat
    ER2, University PMC Paris VI, CeRePP, Paris, France
    Prostate 70:1622-7. 2010
    ..Genetic polymorphism located within the IL16 gene has been reported to be associated with aggressive prostate cancer (PCa). Our aim was to establish whether the tissue expression of IL16 is a prognostic factor of survival in PCa...
  11. doi Prostate needle biopsy examination by means of virtual microscopy
    Cyrus Chargari
    Department of Oncology and Radiotherapy, Val de Grâce Hospital, Paris, France
    Pathol Res Pract 207:366-9. 2011
    ..23, marginal agreement) to 66.2% for virtual slide examination (κ=0.42, good agreement). Virtual microscopy does not compromise, but might improve, the accuracy of grading in prostate needle biopsies. This requires further assessment...
  12. ncbi Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer
    Eva Comperat
    Service d anatomie et cytologie pathologique, hôpital La Pitié Salpêtrière, Paris, France
    Urol Int 82:312-7. 2009
    ..Our series explores protein expression of markers known to be indicators of poor clinical outcome and progression, trying to explain aggressiveness of MPC...
  13. doi Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas
    Nicolas Poté
    Department of Pathology, Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris Descartes University, Paris, France
    Virchows Arch 462:633-8. 2013
    ..From a diagnostic perspective, an array-CGH analysis could be performed in ambiguous ChRCC/RO cases to formally exclude the diagnosis of ChRCC...
  14. doi An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
    Justine Varinot
    Service d Anatomie Pathologique, hôpital La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Int J Surg Pathol 19:285-9. 2011
    ..The authors describe a pigmented renal tumor occurring in a 30-year-old woman with distinct morphology and immunohistochemical characteristics as Xp11 translocation renal cancer...
  15. ncbi Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis
    Eva Comperat
    Service d Anatomie Pathologique, Hopital Pitie Salpetriere, Boulevard de l Hopital, 75013 Paris, France
    Arch Pathol Lab Med 131:965-9. 2007
    ..Splenic metastases occur in a context of multivisceral disseminated cancer or as a solitary lesion...
  16. ncbi Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases
    Eva Comperat
    CNRS UMR 8149, and Service d Anatomie Pathologique, Centre Hospitalier Universitaire Bicêtre, Paris, France
    Urol Int 76:269-73. 2006
    ..EGF-r function and proliferative activity in cyst formation in PKD remains to be explored. EGF-r and Ki-67 expressions are not predictive of development of carcinoma in PKD...
  17. ncbi Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases
    Eva Comperat
    Service Central d Anatomie et Cytologie Pathologiques et d Urologie, hôpital La Pitié Salpêtrière, 83, Bd de l Hopital, 75013 Paris, France
    Virchows Arch 448:319-24. 2006
    ..A statistical difference disserving pTa and pT1/>or=pT2 with a statistical significance (p<10(-6)) could also be observed. P63 should be considered as an additional biomarker that might help pathologists to classify their patients...
  18. ncbi Primitive neuroectodermal tumor of the stomach
    Raoulin Soulard
    Laboratoire d Anatomie Pathologique, Hôpital d Instruction des Armées du Val de Grâce, Paris, France
    Arch Pathol Lab Med 129:107-10. 2005
    ..A multiplex real-time polymerase chain reaction assay detected an EWS-ERG fusion. To our knowledge, this is the first description of a primitive neuroectodermal tumor arising in the stomach...
  19. doi Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder
    Véronique Phé
    Department of Urology, AP HP, Pitié Salpêtrière Academic Hospital, Pierre et Marie Curie Medical School, Paris VI University, Paris, France
    Urology 81:1108.e1-6. 2013
    ..To assess the involvement of connexins (Cxs) 43 and 45 in the selective inhibition of detrusor contractions in patients with neurogenic detrusor overactivity (NDO)...
  20. pmc Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases
    Ahsan Siraj
    Inserm Equipe Angiogenèse Tumorale, Institut Curie, Centre de Recherche, Département Recherche Translationnelle, 26 Rue d Ulm, 75005, Paris, France
    BMC Cancer 13:246. 2013
    ..The Follicle Stimulating Hormone receptor (FSHR) is expressed by the vascular endothelium in a wide range of human tumors. It was not determined however if FSHR is present in metastases which are responsible for the terminal illness...
  21. doi An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps
    Eva Comperat
    Department of Pathology, Groupe Hospitalier La Pitié Salpêtrière, Universite Pierre et Marie Curie, Paris, France
    Histopathology 63:756-66. 2013
    ..We aimed to generate a teaching set of images based on the diagnostic opinions of a panel of expert genitourinary pathologists...
  22. doi Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer
    Eva Comperat
    CNRS UMR 8149, Faculte de Pharmacie, Paris V, Paris, France
    Urology 72:873-7. 2008
    ..We wanted to gain better insight into the early molecular mechanisms of bladder carcinogenesis by evaluating Aurora-A gene expression, which is implicated in genomic stability and essential for mitosis...
  23. ncbi The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy
    Michael Peyromaure
    Department of Urology, Cochin Hospital, Paris, France
    BJU Int 99:1150-3. 2007
    ..To analyse the prognostic value of vascular endothelial growth factor (VEGF) in men with clinically localized prostate cancer...
  24. ncbi The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy
    Kaili Mao
    Department of Urology, Cochin Hospital, 75014 Paris, France
    Oncol Rep 19:171-5. 2008
    ..Our results suggest that VEGFR-1 expression is not associated with the risk of cancer progression following RP. Therefore, VEGFR-1 may not be of prognostic value in clinically-localized PCa...
  25. ncbi [Tumors of the kidneys: new entities]
    Eacute Va Compérat
    Service d Anatomie Pathologique, hôpital La Pitié Salpêtrière, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Ann Pathol 25:117-33. 2005
    ..At least, we will touch on new elements in the Bellini carcinoma definition...
  26. ncbi [Solitary fibrous tumor of the kidney]
    Xavier Durand
    Service d Urologie, Hopital du Val de Grace, 74, boulevard de Port Royal, 75230 Paris
    Prog Urol 13:491-4. 2003
    ....